174 related articles for article (PubMed ID: 11238679)
1. Dendritic cells injected via different routes induce immunity in cancer patients.
Fong L; Brockstedt D; Benike C; Wu L; Engleman EG
J Immunol; 2001 Mar; 166(6):4254-9. PubMed ID: 11238679
[TBL] [Abstract][Full Text] [Related]
2. Dendritic cell gene therapy.
Onaitis M; Kalady MF; Pruitt S; Tyler DS
Surg Oncol Clin N Am; 2002 Jul; 11(3):645-60. PubMed ID: 12487060
[TBL] [Abstract][Full Text] [Related]
3. Dendritic cell-based xenoantigen vaccination for prostate cancer immunotherapy.
Fong L; Brockstedt D; Benike C; Breen JK; Strang G; Ruegg CL; Engleman EG
J Immunol; 2001 Dec; 167(12):7150-6. PubMed ID: 11739538
[TBL] [Abstract][Full Text] [Related]
4. Mammalian and viral IL-10 enhance C-C chemokine receptor 5 but down-regulate C-C chemokine receptor 7 expression by myeloid dendritic cells: impact on chemotactic responses and in vivo homing ability.
Takayama T; Morelli AE; Onai N; Hirao M; Matsushima K; Tahara H; Thomson AW
J Immunol; 2001 Jun; 166(12):7136-43. PubMed ID: 11390459
[TBL] [Abstract][Full Text] [Related]
5. Uncarinic acid C plus IFN-γ generates monocyte-derived dendritic cells and induces a potent Th1 polarization with capacity to migrate.
Bae WK; Umeyama A; Chung IJ; Lee JJ; Takei M
Cell Immunol; 2010; 266(1):104-10. PubMed ID: 20933226
[TBL] [Abstract][Full Text] [Related]
6. Tumor cell lysate-pulsed dendritic cells are more effective than TCR Id protein vaccines for active immunotherapy of T cell lymphoma.
Gatza E; Okada CY
J Immunol; 2002 Nov; 169(9):5227-35. PubMed ID: 12391241
[TBL] [Abstract][Full Text] [Related]
7. Phenotypic profile of dendritic and T cells in the lymph node of Balb/C mice with breast cancer submitted to dendritic cells immunotherapy.
da Cunha A; Antoniazi Michelin M; Cândido Murta EF
Immunol Lett; 2016 Sep; 177():25-37. PubMed ID: 27423825
[TBL] [Abstract][Full Text] [Related]
8. Dendritic cell immunotherapy for urological cancers using cryopreserved allogeneic tumour lysate-pulsed cells: a phase I/II study.
Pandha HS; John RJ; Hutchinson J; James N; Whelan M; Corbishley C; Dalgleish AG
BJU Int; 2004 Aug; 94(3):412-8. PubMed ID: 15291878
[TBL] [Abstract][Full Text] [Related]
9. Routing dependent immune responses after experimental R848-adjuvated vaccination.
van Aalst S; Jansen MAA; Ludwig IS; van der Zee R; van Eden W; Broere F
Vaccine; 2018 Mar; 36(11):1405-1413. PubMed ID: 29409680
[TBL] [Abstract][Full Text] [Related]
10. Mature dendritic cells pulsed with exosomes stimulate efficient cytotoxic T-lymphocyte responses and antitumour immunity.
Hao S; Bai O; Li F; Yuan J; Laferte S; Xiang J
Immunology; 2007 Jan; 120(1):90-102. PubMed ID: 17073943
[TBL] [Abstract][Full Text] [Related]
11. Mage-3 and influenza-matrix peptide-specific cytotoxic T cells are inducible in terminal stage HLA-A2.1+ melanoma patients by mature monocyte-derived dendritic cells.
Schuler-Thurner B; Dieckmann D; Keikavoussi P; Bender A; Maczek C; Jonuleit H; Röder C; Haendle I; Leisgang W; Dunbar R; Cerundolo V; von Den Driesch P; Knop J; Bröcker EB; Enk A; Kämpgen E; Schuler G
J Immunol; 2000 Sep; 165(6):3492-6. PubMed ID: 10975870
[TBL] [Abstract][Full Text] [Related]
12. Comparison of alpha-Type-1 polarizing and standard dendritic cell cytokine cocktail for maturation of therapeutic monocyte-derived dendritic cell preparations from cancer patients.
Trepiakas R; Pedersen AE; Met O; Hansen MH; Berntsen A; Svane IM
Vaccine; 2008 Jun; 26(23):2824-32. PubMed ID: 18450338
[TBL] [Abstract][Full Text] [Related]
13. Interferon-alpha disables dendritic cell precursors: dendritic cells derived from interferon-alpha-treated monocytes are defective in maturation and T-cell stimulation.
Dauer M; Pohl K; Obermaier B; Meskendahl T; Röbe J; Schnurr M; Endres S; Eigler A
Immunology; 2003 Sep; 110(1):38-47. PubMed ID: 12941139
[TBL] [Abstract][Full Text] [Related]
14. Route of administration modulates the induction of dendritic cell vaccine-induced antigen-specific T cells in advanced melanoma patients.
Lesterhuis WJ; de Vries IJ; Schreibelt G; Lambeck AJ; Aarntzen EH; Jacobs JF; Scharenborg NM; van de Rakt MW; de Boer AJ; Croockewit S; van Rossum MM; Mus R; Oyen WJ; Boerman OC; Lucas S; Adema GJ; Punt CJ; Figdor CG
Clin Cancer Res; 2011 Sep; 17(17):5725-35. PubMed ID: 21771874
[TBL] [Abstract][Full Text] [Related]
15. Clinical grade OK432-activated dendritic cells: in vitro characterization and tracking during intralymphatic delivery.
West E; Morgan R; Scott K; Merrick A; Lubenko A; Pawson D; Selby P; Hatfield P; Prestwich R; Fraser S; Eves D; Anthoney A; Twelves C; Beirne D; Patel P; O'Donnell D; Watt S; Waller M; Dietz A; Robinson P; Melcher A
J Immunother; 2009 Jan; 32(1):66-78. PubMed ID: 19307995
[TBL] [Abstract][Full Text] [Related]
16. Intradermal injections of polyarginine-containing immunogenic antigens preferentially elicit Tc1 and Th1 activation and antitumour immunity.
Mitsui H; Okamoto T; Kanzaki M; Inozume T; Shibagaki N; Shimada S
Br J Dermatol; 2010 Jan; 162(1):29-41. PubMed ID: 19863514
[TBL] [Abstract][Full Text] [Related]
17. Strategies for antigen choice and priming of dendritic cells influence the polarization and efficacy of antitumor T-cell responses in dendritic cell-based cancer vaccination.
Galea-Lauri J; Wells JW; Darling D; Harrison P; Farzaneh F
Cancer Immunol Immunother; 2004 Nov; 53(11):963-77. PubMed ID: 15146294
[TBL] [Abstract][Full Text] [Related]
18. [Dendritic cells present particulate E7 protein of human papillomavirus and induce strong immunity].
Li J; Gao HQ; Zhao CL; Li LZ; Ji CY; Hou M; Plebaski M
Zhonghua Yi Xue Za Zhi; 2004 Jun; 84(11):932-6. PubMed ID: 15329282
[TBL] [Abstract][Full Text] [Related]
19. Eliciting T cell immunity against poorly immunogenic tumors by immunization with dendritic cell-tumor fusion vaccines.
Wang J; Saffold S; Cao X; Krauss J; Chen W
J Immunol; 1998 Nov; 161(10):5516-24. PubMed ID: 9820528
[TBL] [Abstract][Full Text] [Related]
20. Prostaglandin D2 affects the differentiation and functions of human dendritic cells: impact on the T cell response.
Gosset P; Pichavant M; Faveeuw C; Bureau F; Tonnel AB; Trottein F
Eur J Immunol; 2005 May; 35(5):1491-500. PubMed ID: 15816013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
